REFERENCES
1. Veis DJ, O’brien CA. Osteoclasts, master sculptors of bone. Annu Rev Pathol Mech Dis. 2023;18:257-81.
2. Li ZG, Mathew P, Yang J, et al. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest. 2008;118:2697-710.
3. Sims NA, Martin TJ. Osteoclasts provide coupling signals to osteoblast lineage cells through multiple mechanisms. Annu Rev Physiol. 2020;82:507-29.
4. Zhang T, Feng Y, Wang W, et al. Membrane-bound or soluble, mesenchymal or myeloid: which RANKL drives osteoclastogenesis? J Transl Genet Genom. 2026;10:74-88.
5. Wu Y, Gan D, Liu Z, et al. Osteocytes: master orchestrators of skeletal homeostasis, remodeling, and osteoporosis pathogenesis. Front. Cell Dev. Biol. 2025;13:1670716.
6. Cawthray JF, Weekes DM, Sivak O, et al. In vivo study and thermodynamic investigation of two lanthanum complexes, La(dpp)3 and La(XT), for the treatment of bone resorption disorders. Chem. Sci. 2015;6:6439-47.
7. Markmiller S, Soltanieh S, Server KL, et al. Context-dependent and disease-specific diversity in protein interactions within stress granules. Cell. 2018;172:590-604.e13.
8. Gebauer F, Schwarzl T, Valcárcel J, Hentze MW. RNA-binding proteins in human genetic disease. Nat Rev Genet. 2020;22:185-98.
9. Mosca R, Gallardo-dodd CJ, Li Q, et al. RAPseq enables large-scale identification of RBP-RNA interactions and reveals essentials of post-transcriptional gene regulation. Nucleic Acids Res. 2026;54:gkag090.
10. Hentze MW, Sommerkamp P, Ravi V, Gebauer F. Rethinking RNA-binding proteins: riboregulation challenges prevailing views. Cell. 2025;188:4811-27.
11. Seufert L, Benzing T, Ignarski M, Müller R. RNA-binding proteins and their role in kidney disease. Nat Rev Nephrol. 2021;18:153-70.
12. Wang S, Sun Z, Lei Z, Zhang H. RNA-binding proteins and cancer metastasis. Semin Cancer Biol. 2022;86:748-68.
13. Paschalis A, Sharp A, Welti JC, et al. Alternative splicing in prostate cancer. Nat Rev Clin Oncol. 2018;15:663-75.
14. Fu X, Ares M. Context-dependent control of alternative splicing by RNA-binding proteins. Nat Rev Genet. 2014;15:689-701.
15. Watanabe H, Shionyu M, Kimura T, Kimata K, Watanabe H. Splicing factor 3b subunit 4 binds BMPR-IA and inhibits osteochondral cell differentiation. J Biol Chem. 2007;282:20728-38.
16. Hata K, Nishimura R, Muramatsu S, et al. Paraspeckle protein p54nrb links Sox9-mediated transcription with RNA processing during chondrogenesis in mice. J Clin Invest. 2008;118:3098-108.
17. Koscielny G, Texier VL, Gopalakrishnan C, et al. ASTD: The alternative splicing and transcript diversity database. Genomics. 2009;93:213-20.
18. Tian B, Manley JL. Alternative cleavage and polyadenylation: the long and short of it. Trends Biochem Sci. 2013;38:312-20.
19. Khajuria DK, Nowak I, Leung M, et al. Transcript shortening via alternative polyadenylation promotes gene expression during fracture healing. Bone Res. 2023;11:5.
20. Truitt ML, Ruggero D. New frontiers in translational control of the cancer genome. Nat Rev Cancer. 2016;16:288-304.
21. Zou L, Xiang C, Lu M. MSI1 Stabilizes MACF1 to inhibit apoptosis of MC3T3-E1 cells induced by high glucose and promote osteogenic differentiation through Wnt/β-catenin signaling pathway. Mol Biotechnol. 2022;65:1085-95.
22. Suo J, Zou S, Wang J, et al. The RNA-binding protein Musashi2 governs osteoblast-adipocyte lineage commitment by suppressing PPARγ signaling. Bone Res. 2022;10:31.
23. Fujiwara T, Zhou J, Ye S, Zhao H. RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival. Cell Death Dis. 2016;7:e2300.
24. Niu N, Xiang J, Yang Q, et al. RNA-binding protein SAMD4 regulates skeleton development through translational inhibition of Mig6 expression. Cell Discov. 2017;3:16050.
25. Roux ME, Rasmussen MW, Palma K, et al. The mRNA decay factor PAT1 functions in a pathway including MAP kinase 4 and immune receptor SUMM2. EMBO J. 2015;34:593-608.
26. Chen XS, Brown CM. Computational identification of new structured cis -regulatory elements in the 3’-untranslated region of human protein coding genes. Nucleic Acids Res. 2012;40:8862-73.
27. Cook ME, Bradstreet TR, Webber AM, et al. The ZFP36 family of RNA binding proteins regulates homeostatic and autoreactive T cell responses. Sci. Immunol. 2022;7:eabo0981.
28. Zhang L, Kwack KH, Thiyagarajan R, et al. Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid‐derived suppressor cells. The FASEB Journal. 2023;38:e23338.
29. Tseng K, Chen Y, Lin S. Zinc finger protein ZFP36L1 promotes osteoblastic differentiation but represses adipogenic differentiation of mouse multipotent cells. Oncotarget. 2017;8:20588-601.
30. Son Y, Kim H, Choi W, Chun C, Chun J. RNA-binding protein ZFP36L1 regulates osteoarthritis by modulating members of the heat shock protein 70 family. Nat Commun. 2019;10:77.
31. Liu Z, Li B, Hu H, Li X, Zhang X. Potential of RNA-binding protein human antigen R as a driver of osteogenic differentiation in osteoporosis. J Orthop Surg Res. 2022;17:234.
32. Guo Y, Tang CY, Man XF, et al. Insulin‐like growth factor‐1 promotes osteogenic differentiation and collagen I alpha 2 synthesis via induction of mRNA‐binding protein LARP6 expression. Dev Growth Differ. 2017;59:94-103.
33. Chen G, Long C, Wang S, et al. RETRACTED ARTICLE: circular RNA circStag1 promotes bone regeneration by interacting with HuR. Bone Res. 2022;10:32.
34. Fan Z, Kitaura H, Marahleh A, et al. HuR knockdown in MLO-Y4 osteocyte-like cells elevates OPG expression and suppresses osteoclastogenesis in vitro. Int J Mol Sci. 2025;27:430.
35. Doxtader KA, Wang P, Scarborough AM, Seo D, Conrad NK, Nam Y. Structural basis for regulation of METTL16, an S-adenosylmethionine homeostasis factor. Mol Cell. 2018;71:1001-1011.e4.
36. He M, Lei H, He X, et al. METTL14 regulates osteogenesis of bone marrow mesenchymal stem cells via inducing autophagy through m6A/IGF2BPs/beclin-1 signal axis. Stem Cells Translational Medicine. 2022;11:987-1001.
37. Deng M, Luo J, Cao H, Li Y, Chen L, Liu G. METTL14 represses osteoclast formation to ameliorate osteoporosis via enhancing GPX4 mRNA stability. Environ Toxicol. 2023;38:2057-68.
38. Kong Y, Zhang Y, Cai Y, Li D, Yi B, Xu Q. METTL3 mediates osteoblast apoptosis by regulating endoplasmic reticulum stress during LPS-induced inflammation. Cell Signal. 2022;95:110335.
39. Zhang Y, Gu X, Li D, Cai L, Xu Q. METTL3 regulates osteoblast differentiation and inflammatory response via smad signaling and MAPK signaling. Int J Mol Sci. 2019;21:199.
40. Mi B, Xiong Y, Yan C, et al. Methyltransferase‐like 3‐mediated N6‐methyladenosine modification of miR‐7212‐5p drives osteoblast differentiation and fracture healing. J Cell Mol Med. 2020;24:6385-96.
41. He Y, Wang W, Xu X, et al. Mettl3 inhibits the apoptosis and autophagy of chondrocytes in inflammation through mediating Bcl2 stability via Ythdf1-mediated m6A modification. Bone. 2022;154:116182.
42. He Y, Wang W, Luo P, et al. Mettl3 regulates hypertrophic differentiation of chondrocytes through modulating Dmp1 mRNA via Ythdf1-mediated m6A modification. Bone. 2022;164:116522.
43. Xiao L, Hu B, Ding B, et al. N(6)-methyladenosine RNA methyltransferase like 3 inhibits extracellular matrix synthesis of endplate chondrocytes by downregulating sex-determining region Y-Box transcription factor 9 expression under tension. Osteoarthritis Cartilage. 2022;30:613-25.
44. Wang W, Qiao S, Wu X, et al. Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation. Cell Death Dis. 2021;12:628.
45. Zhuang J, Ning H, Wang M, et al. Downregulated fat mass and obesity-associated protein inhibits bone resorption and osteoclastogenesis by nuclear factor-kappa B inactivation. Cell Signal. 2021;87:110137.
46. He J, Zhao Y, Zhang Y, Zhang Z, Li D, Xu Q. FTO regulates osteoclast development by modulating the proliferation and apoptosis of osteoclast precursors in inflammatory conditions. Cell Signal. 2024;117:111098.
47. Li Z, Wang P, Li J, et al. The N6-methyladenosine demethylase ALKBH5 negatively regulates the osteogenic differentiation of mesenchymal stem cells through PRMT6. Cell Death Dis. 2021;12:578.
48. Liu T, Zheng X, Wang C, et al. The m6A “reader” YTHDF1 promotes osteogenesis of bone marrow mesenchymal stem cells through translational control of ZNF839. Cell Death Dis. 2021;12:1078.
49. Zhou Z, Chen S, Wu T, et al. IGF2BP2, an RNA‐binding protein regulates cell proliferation and osteogenic differentiation by stabilizing SRF mRNA. J Cell Physiol. 2022;238:195-209.
50. Yang H, Wang W, Liu H, et al. miR615‐3p inhibited FBLN1 and osteogenic differentiation of umbilical cord mesenchymal stem cells by associated with YTHDF2 in a m6A‐miRNA interaction manner. Cell Prolif. 2024;57:e13607.
51. Wu J, Niu L, Yang K, et al. The role and mechanism of RNA-binding proteins in bone metabolism and osteoporosis. Ageing Res Rev. 2024;96:102234.
52. Du T, Yan Z, Zhu S, et al. QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism. Cell Death Dis. 2020;11:330.
53. Zhou Y, Yang Y, Liu Y, et al. Irp2 knockout causes osteoporosis by inhibition of bone remodeling. Calcif Tissue Int. 2018;104:70-8.
54. Yan G, Yuan Y, He M, et al. m6A methylation of precursor-miR-320/RUNX2 controls osteogenic potential of bone marrow-derived mesenchymal stem cells. Molecular Therapy - Nucleic Acids. 2020;19:421-36.
55. Richard S, Torabi N, Franco GV, et al. Ablation of the Sam68 RNA binding protein protects mice from age-related bone loss. PLoS Genet. 2005;1:e74.
56. Yoon DS, Choi Y, Lee K, et al. Downregulation of the RNA-binding protein PUM2 facilitates MSC-driven bone regeneration and prevents OVX-induced bone loss. J Biomed Sci. 2023;30:26.
57. Liu J, You Y, Sun Z, et al. WTAP-mediated m6A RNA methylation regulates the differentiation of bone marrow mesenchymal stem cells via the miR-29b-3p/HDAC4 Axis. Stem Cells Translational Medicine. 2023;12:307-21.
58. Li D, Liu J, Yang C, et al. Targeting long noncoding RNA PMIF facilitates osteoprogenitor cells migrating to bone formation surface to promote bone formation during aging. Theranostics. 2021;11:5585-604.
59. Huai Y, Wang X, Mao W, et al. HuR‐positive stress granules: potential targets for age‐related osteoporosis. Aging Cell. 2024;23:e14053.
60. Yang J, Sun B, Wang Z, et al. Exosome-targeted delivery of METTL14 regulates NFATc1 m6A methylation levels to correct osteoclast-induced bone resorption. Cell Death Dis. 2023;14:738.
61. Li G, Zhang W, Liang H, Yang C. Epigenetic regulation in intervertebral disc degeneration. Trends Mol Med. 2022;28:803-5.
62. Sun K, Jiang J, Wang Y, et al. The role of nerve fibers and their neurotransmitters in regulating intervertebral disc degeneration. Ageing Res Rev. 2022;81:101733.
63. Francisco V, Pino J, González-gay MÁ, et al. A new immunometabolic perspective of intervertebral disc degeneration. Nat Rev Rheumatol. 2021;18:47-60.
64. Wang JJ, Liu XY, Du W, Liu JQ, Sun B, Zheng YP. RBMS3 delays disc degeneration by inhibiting Wnt/β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2020;24:499-507.
65. Shao Z, Tu Z, Shi Y, et al. RNA-Binding Protein HuR Suppresses Inflammation and Promotes Extracellular Matrix Homeostasis via NKRF in Intervertebral Disc Degeneration. Front. Cell Dev. Biol. 2020;8:611234.
66. Shao Z, Ni L, Hu S, et al. RNA‐binding protein HuR suppresses senescence through Atg7 mediated autophagy activation in diabetic intervertebral disc degeneration. Cell Prolif. 2020;54:e12975.
67. Li G, Ma L, He S, et al. WTAP-mediated m6A modification of lncRNA NORAD promotes intervertebral disc degeneration. Nat Commun. 2022;13:1469.
68. Xu C, Zhang Z, Liu N, et al. Small extracellular vesicle-mediated miR-320e transmission promotes osteogenesis in OPLL by targeting TAK1. Nat Commun. 2022;13:2467.
69. Jokoji G, Maeda S, Oishi K, et al. CDC5L promotes early chondrocyte differentiation and proliferation by modulating pre-mRNA splicing of SOX9, COL2A1, and WEE1. J Biol Chem. 2021;297:100994.
70. Yuan X, Shi L, Guo Y, et al. METTL3 regulates ossification of the posterior longitudinal ligament via the lncRNA XIST/miR-302a-3p/USP8 axis. Front. Cell Dev. Biol. 2021;9:629895.
71. Brown MA, Kenna T, Wordsworth BP. Genetics of ankylosing spondylitis-insights into pathogenesis. Nat Rev Rheumatol. 2015;12:81-91.
72. Luo Q, Guo Y, Xiao Q, et al. Expression and clinical significance of the m6A RNA-binding proteins YTHDF2 in peripheral blood mononuclear cells from new-onset ankylosing spondylitis. Front. Med. 2022;9:922219.
73. Zong H, Liu Y, Wang X, et al. RIOK3 potentially regulates osteogenesis-related pathways in ankylosing spondylitis and the differentiation of bone marrow mesenchymal stem cells. Genomics. 2023;115:110730.
74. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6:625-35.
75. Kapoor M, Martel-pelletier J, Lajeunesse D, Pelletier J, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2010;7:33-42.
76. Yi Q, Deng Z, Yue J, et al. RNA binding proteins in osteoarthritis. Front. Cell Dev. Biol. 2022;10:954376.
77. Jouan Y, Bouchemla Z, Bardèche-trystram B, et al. Lin28a induces SOX9 and chondrocyte reprogramming via HMGA2 and blunts cartilage loss in mice. Sci. Adv. 2022;8:eabn3106.
78. Kobayashi T, Kozlova A. Lin28a overexpression reveals the role of Erk signaling in articular cartilage development. Development. 2018;145:dev162594.
79. Chen X, Gong W, Shao X, et al. METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression. Ann Rheum Dis. 2022;81:87-99.
80. Yoon DS, Lee K, Choi Y, et al. TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis. Cell Death Differ. 2022;29:1364-78.
81. Xiao Y, Chen L, Chen D, et al. FSCN1 induces subchondral bone sclerosis in osteoarthritis via modulating actin cytoskeleton dynamics and YAP signaling. Arthritis Res Ther. 2026;28:33.
82. Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020;16:316-33.
83. Luo Q, Gao Y, Zhang L, et al. Decreased ALKBH5, FTO, and YTHDF2 in Peripheral blood are as risk factors for rheumatoid arthritis. Biomed Res Int. 2020;2020:5735279.
84. Yao F, Xu C, Gao Y, et al. Expression and clinical significance of the m6A reader YTHDF2 in peripheral blood mononuclear cells from rheumatoid arthritis patients. J Immunotoxicol. 2022;19:53-60.
85. Wu S, Li X, Wu Y, Yin S, Huang C, Li J. N6-methyladenosine and rheumatoid arthritis: a comprehensive review. Front. Immunol. 2021;12:731842.
86. Cao X, Li P, Song X, et al. PCBP1 is associated with rheumatoid arthritis by affecting RNA products of genes involved in immune response in Th1 cells. Sci Rep. 2022;12:8398.
87. Ma Z, Zhou Y, Wang Y, et al. RNA-binding protein hnRNP UL1 binds κB sites to attenuate NF-κB-mediated inflammation. J Autoimmun. 2022;129:102828.
88. Li Q, Guo H, Li H, Zhu Q, Liu Y. P54/nrb prompts rheumatoid arthritis progression mainly by transcriptionally activating NF-κB signaling. Pharmazie. 2017;72:260-4.
89. Sun W, Qin R, Wang R, et al. Sam68 promotes invasion, migration, and proliferation of fibroblast-like synoviocytes by enhancing the NF-κB/P65 pathway in rheumatoid arthritis. Inflammation. 2018;41:1661-70.
90. Herdy B, Karonitsch T, Vladimer GI, et al. The RNA‐binding protein HuR/ELAVL1 regulates IFN‐β mRNA abundance and the type I IFN response. Eur J Immunol. 2015;45:1500-11.
91. Johnston JJ, Teer JK, Cherukuri PF, et al. Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate. Am J Hum Genet. 2010;86:743-8.
92. Rodor J, Fitzpatrick DR, Eyras E, Cáceres JF. The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development. RNA Biol. 2016;14:45-57.
93. Bernier FP, Caluseriu O, Ng S, et al. Haploinsufficiency of SF3B4, a component of the Pre-mRNA spliceosomal complex, causes nager syndrome. Am J Hum Genet. 2012;90:925-33.
94. Mcpherson E, Zaleski C, Ye Z, Lin S. Rodriguez syndrome with SF3B4 mutation: a severe form of nager syndrome? Am J Med Genet A. 2014;164:1841-5.
95. Marques F, Tenney J, Duran I, et al. Altered mRNA splicing, chondrocyte gene expression and abnormal skeletal development due to SF3B4 mutations in rodriguez acrofacial dysostosis. PLoS Genet. 2016;12:e1006307.
96. Yamada T, Takechi M, Yokoyama N, et al. Heterozygous mutation of the splicing factor Sf3b4 affects development of the axial skeleton and forebrain in mouse. Dev Dyn. 2020;249:622-35.
97. Heike C, Hing A, Aspinall C, et al. Clinical care in craniofacial microsomia: a review of current management recommendations and opportunities to advance research. Am J Med Genet C Semin Med Genet. 2013;163:271-82.
98. Timberlake AT, Griffin C, Heike CL, et al. ; University of Washington Center for Mendelian Genomics. Haploinsufficiency of SF3B2 causes craniofacial microsomia. Nat Commun. 2021;12:4680.
99. Rao S, Watt K, Maili L, et al. Splicing defects and cell death cause SF3B2-linked craniofacial microsomia. J Dent Res. 2025;104:1116-26.
100. Favaro FP, Alvizi L, Zechi-ceide RM, et al. A noncoding expansion in EIF4A3 causes richieri-costa-pereira syndrome, a craniofacial disorder associated with limb defects. Am J Hum Genet. 2014;94:120-8.
101. Miller EE, Kobayashi GS, Musso CM, et al. EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome. Hum Mol Genet. 2017;26:2177-91.
102. Qi X, Pang Q, Wang J, et al. Familial early-onset paget’s disease of bone associated with a novel hnRNPA2B1 mutation. Calcif Tissue Int. 2017;101:159-69.
103. Kim HJ, Kim NC, Wang Y, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467-73.
104. Albers CA, Paul DS, Schulze H, et al. Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet. 2012;44:435-9.
105. Mao H, Pilaz L, Mcmahon JJ, et al. Rbm8a haploinsufficiency disrupts embryonic cortical development resulting in microcephaly. J. Neurosci. 2015;35:7003-18.
106. Kocere A, Chiavacci E, Soneson C, et al. Rbm8a deficiency causes hematopoietic defects by modulating Wnt/PCP signaling. Dev Biol. 2025;528:34-56.
107. El Chehadeh S, Kerstjens-frederikse WS, Thevenon J, et al. Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature. Eur J Hum Genet. 2016;25:43-51.
108. Lines MA, Huang L, Schwartzentruber J, et al. Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly. Am J Hum Genet. 2012;90:369-77.
109. Chen L, Li Y, Yu Y, et al. EFTUD2 regulates cortical morphogenesis via modulation of Caspase‐3 and Aifm1 splicing pathways. Adv Sci. 2025;12:e04200.
110. Alazami AM, Al-owain M, Alzahrani F, et al. Loss of function mutation in LARP7, chaperone of 7SK ncRNA, causes a syndrome of facial dysmorphism, intellectual disability, and primordial dwarfism. Hum Mutat. 2012;33:1429-34.
111. Hasler D, Meduri R, Bąk M, et al. The alazami syndrome-associated protein LARP7 guides U6 small nuclear RNA modification and contributes to splicing robustness. Mol Cell. 2020;77:1014-1031.e13.
112. Voraberger B, Mayr JA, Fratzl-zelman N, et al. Investigating the role of ASCC1 in the causation of bone fragility. Front. Endocrinol. 2023;14:1137573.
113. Knierim E, Hirata H, Wolf NI, et al. Mutations in subunits of the activating signal cointegrator 1 complex are associated with prenatal spinal muscular atrophy and congenital bone fractures. Am J Hum Genet. 2016;98:473-89.
114. Choufani S, Mcniven V, Cytrynbaum C, et al. An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome. Am J Hum Genet. 2022;109:1867-84.
115. Chen Y, Wu J, Zhang S, et al. Hnrnpk maintains chondrocytes survival and function during growth plate development via regulating Hif1α-glycolysis axis. Cell Death Dis. 2022;13:803.
116. Chen Y, Yang B, Zhang XM, et al. Biallelic variants in RBM42 cause a multisystem disorder with neurological, facial, cardiac, and musculoskeletal involvement. Protein Cell. 2024;15:52-68.
117. Alonso-gil D, Losada A. NIPBL and cohesin: new take on a classic tale. Trends Cell Biol. 2023;33:860-71.
118. Krantz ID, Mccallum J, Descipio C, et al. Cornelia de Lange syndrome is caused by mutations in NIPBL, the human homolog of drosophila melanogaster nipped-B. Nat Genet. 2004;36:631-5.
119. Gu W, Wang L, Gu R, et al. Defects of cohesin loader lead to bone dysplasia associated with transcriptional disturbance. J Cell Physiol. 2021;236:8208-25.
120. Kawauchi S, Calof AL, Santos R, et al. Multiple organ system defects and transcriptional dysregulation in the Nipbl+/- mouse, a model of cornelia de lange syndrome. PLoS Genet. 2009;5:e1000650.
121. Chea S, Kreger J, Lopez-burks ME, Maclean AL, Lander AD, Calof AL. Gastrulation-stage gene expression in Nipbl+/- mouse embryos foreshadows the development of syndromic birth defects. Sci. Adv. 2024;10:eadl4239.
122. Guo L, Salian S, Xue J, et al. Null and missense mutations of ERI1 cause a recessive phenotypic dichotomy in humans. Am J Hum Genet. 2023;110:1068-85.
123. Ueki Y, Tiziani V, Santanna C, et al. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet. 2001;28:125-6.
124. Chester JG, Carcamo B, Gudis DA, et al. PLCG2 variants in cherubism. J Allergy Clin Immunol. 2024;154:1554-8.
125. Yoshimoto T, Hayashi T, Kondo T, Kittaka M, Reichenberger EJ, Ueki Y. Second-generation SYK inhibitor entospletinib ameliorates fully established inflammation and bone destruction in the cherubism mouse model. J Bone Miner Res. 2018;33:1513-9.
126. Forman TE, Dennison BJC, Fantauzzo KA. The role of RNA-binding proteins in vertebrate neural crest and craniofacial development. J Dev Biol. 2021;9:34.
127. Lehalle D, Wieczorek D, Zechi‐ceide R, et al. A review of craniofacial disorders caused by spliceosomal defects. Clin Genet. 2015;88:405-15.
128. Blackwell DL, Fraser SD, Caluseriu O, et al. Hnrnpul1 controls transcription, splicing, and modulates skeletal and limb development in vivo. G3 (Bethesda). 2022;12:jkac067.
129. Dennison BJC, Larson ED, Fu R, Mo J, Fantauzzo KA. Srsf3 mediates alternative RNA splicing downstream of PDGFRα signaling in the facial mesenchyme. Development. 2021;148:dev199448.
130. Dash S, Trainor PA. Nucleolin loss of function leads to aberrant fibroblast growth factor signaling and craniofacial anomalies. Development. 2022;149:dev200349.
131. Cibi DM, Mia MM, Guna Shekeran S, et al. Neural crest-specific deletion of Rbfox2 in mice leads to craniofacial abnormalities including cleft palate. eLife. 2019;8:e45418.
132. Jayasena CS, Bronner ME. Rbms3 functions in craniofacial development by posttranscriptionally modulating TGF-β signaling. J Cell Biol. 2012;199:453-66.
133. Hawkins S, Mondaini A, Namboori SC, et al. ePRINT: exonuclease assisted mapping of protein-RNA interactions. Genome Biol. 2024;25:140.
